metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-37 ASSESSMENT OF METABOLIC ASSOCIATED FATTY LIVER DISEASE, ALCOHOLIC LIVER DIS...
Journal Information
Vol. 28. Issue S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(March 2023)
Share
Share
Download PDF
More article options
Vol. 28. Issue S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(March 2023)
Full text access
P-37 ASSESSMENT OF METABOLIC ASSOCIATED FATTY LIVER DISEASE, ALCOHOLIC LIVER DISEASE, AND DUAL DAMAGE IN APPARENTLY HEALTHY BLOOD BANK INDIVIDUALS
Visits
190
Jorge Emilio Lira-Vera, O Morales-Gutiérrez, Farid Yael Vargas-Durán, Pablo Alagón-Fernández Del Campo, Ana Karen Soto Martínez, Diana Montemira-Orozco, Andrés Burak-Leipuner, Christian Hinojosa-Segura, Gabriela Gutiérrez-Reyes, Moisés Martínez-Castillo, Samantha Sánchez-Valle, María De Los Ángeles Lemus-Peña, Daniel Montes De Oca-Ángeles, Abigail Hernández-Barragán, Marisela Hernández-Santillán, María De Fátima Higuera-De La Tijera, Yadira Lilian Béjar-Ramírez, José Luis Pérez-Hernández
Gastroenterology and Hepatology Department, Hospital General de México "Dr. Eduardo Liceaga," Mexico City, Mexico
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 28. Issue S1

Abstracts of the 2022 Annual Meeting of the ALEH

More info
Introduction and Objectives

metabolic syndrome and alcohol consumption are the leading causes of fatty liver disease. Now, a new term called dual damage has emerged. So far, no studies are reporting the prevalence of dual damage in Mexico. This study aimed to determine the prevalence of metabolic associated fatty liver disease, alcoholic liver disease, and dual damage in the healthy population of the blood bank of our center.

Materials and Methods

descriptive, cross-sectional, prolective study. We included donors ≥18 years old. We excluded subjects with known liver disease. Vibration-controlled transient hepatic elastography was the method of estimating steatosis and liver fibrosis. We used descriptive statistics.

Results

258 donors were included; 129 (50%) have hepatic steatosis: 67 (25.96%) metabolic associated, 31 (12.01%) due to alcohol, and 31 (12.01%) by dual damage. In the metabolic group, S1 was found in 14 subjects (20.90%), S2 in 23 (34.32%), and S3 in 30 (44.78%). 23 (34.32%) were overweight, 23 (34.32%) had obesity grade 1, 11 (16.44%) grade 2, and 5 (7.46%) grade 3. Of the alcohol damage group, 12 (38.70%) had S1, 5 (19.35%) S2, and 13 (41.95%) S3. Beer was the most frequently consumed beverage (61.29%), with the excessive pattern being the most frequent (74.19%), with an average intake of 90.25 grams. 100% of donors with dual damage presented S3 steatosis. Advanced fibrosis was found in 3 (4.47%) metabolic damage donors, 1 (3.22%) by alcohol, and 2 (6.45%) by dual damage.

Conclusions

5 out of 10 apparently healthy individuals have fatty liver disease. The most frequent was due to metabolic damage, while fatty liver disease due to alcohol and dual damage were equally prevalent. Undiagnosed advanced fibrosis was found in a small percentage. These individuals are a sample of the Mexican population that could represent the behavior of the population of our country.

Full text is only aviable in PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos